Cover Image
Read Now

Ivermectin for parasitic skin infections of scabies a review of comparative clinical effectiveness, cost-effectiveness, and guidelines

Scabies is a skin condition caused by the parasitic infestation of the mite Sarcoptes scabiei. Scabies results in intense, debilitating itching and skin papules, nodules, and vesicles and is transmitted through direct contact. In a small proportion of cases, typically in those with immunosuppression...

Full description

Bibliographic Details
Main Authors: Chiu, Stephanie, Argáez, Charlene (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa CADTH May 16, 2019, 2019
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Canada
Ivermectin
Antiparasitic Agents
Administration, Oral
Cost-benefit Analysis
Treatment Outcome
Scabies / Drug Therapy
Administration, Topical
Practice Guidelines As Topic
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02254nam a2200373 u 4500
001 EB001897069
003 EBX01000000000000001060074
005 00000000000000.0
007 tu|||||||||||||||||||||
008 200523 r ||| eng
100 1 |a Chiu, Stephanie 
245 0 0 |a Ivermectin for parasitic skin infections of scabies  |h Elektronische Ressource  |b a review of comparative clinical effectiveness, cost-effectiveness, and guidelines  |c Stephanie Chiu and Charlene Argaez 
250 |a Version 1.0 
260 |a Ottawa  |b CADTH  |c May 16, 2019, 2019 
300 |a 1 PDF file (35 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Canada 
653 |a Ivermectin 
653 |a Antiparasitic Agents 
653 |a Administration, Oral 
653 |a Cost-Benefit Analysis 
653 |a Treatment Outcome 
653 |a Scabies / drug therapy 
653 |a Administration, Topical 
653 |a Practice Guidelines as Topic 
700 1 |a Argáez, Charlene  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
710 2 |a Canadian Agency for Drugs and Technologies in Health  |b Rapid Response Service 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report: summary with critical appraisal 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK545083  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Scabies is a skin condition caused by the parasitic infestation of the mite Sarcoptes scabiei. Scabies results in intense, debilitating itching and skin papules, nodules, and vesicles and is transmitted through direct contact. In a small proportion of cases, typically in those with immunosuppression, hyperinfestation and crusted scabies can develop and lead to secondary bacterial infection associated with significant morbidity and mortality. The Global Burden of Disease study estimated that the global prevalence of scabies was approximately 200 million in 2015. High prevalence of scabies is associated with tropical regions, resource-poor settings, and overcrowded settings. Outbreaks of scabies have previously been reporting in chronic health care facilities in Canada 

Similar Items